Jade Biosciences (JBIO) Retained Earnings (2020 - 2026)
Jade Biosciences (JBIO) reported Retained Earnings of -$342000.0 for Q1 2026, down 784.0% on a YoY basis from $50000.0 in Q1 2025, and down 365.12% quarter-over-quarter from $129000.0 in Q4 2025.
Jade Biosciences (JBIO) Retained Earnings (2020 - 2026) Analysis & Trends
Jade Biosciences has reported Retained Earnings for 7 years, with the latest figure at -$342000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 784.0% year-over-year to -$342000.0; the trailing twelve-month figure through Mar 2026 stood at -$342000.0 (down 784.0% YoY), and the FY2025 full-year result was $129000.0, up 100.27% from the prior year.
- Retained Earnings for Q1 2026 stood at -$342000.0, down from $129000.0 in the prior quarter.
- The five-year high for Retained Earnings was $129000.0 in Q4 2025, with the low at -$227.6 million in Q3 2024.
- Historically, Retained Earnings has averaged -$83.8 million across 5 years, with a median of -$72.9 million in 2022.
- Annual changes were most pronounced in 2024 — Retained Earnings slumped 94691.48% — and 2025, when it surged 251.52%.
- Jade Biosciences' Retained Earnings stood at -$87.9 million in 2022, then sank by 85.91% to -$163.4 million in 2023, then jumped by 71.25% to -$47.0 million in 2024, then jumped by 100.27% to $129000.0 in 2025, then sank by 365.12% to -$342000.0 in 2026.
- The last three Retained Earnings figures came in at -$342000.0 (Q1 2026), $129000.0 (Q4 2025), and -$142.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Jade Biosciences | 973.55 Mn | 973.55 Mn | - | -342,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -342,000.00 |
| Dec 31, 2025 | 129,000.00 |
| Sep 30, 2025 | -142.46 Mn |
| Jun 30, 2025 | -117.28 Mn |
| Mar 31, 2025 | 50,000.00 |
| Dec 31, 2024 | -46.98 Mn |
| Sep 30, 2024 | -227.62 Mn |
| Jun 30, 2024 | -211.39 Mn |
| Mar 31, 2024 | -33,000.00 |
| Dec 31, 2023 | -163.42 Mn |
| Sep 30, 2023 | -143.01 Mn |
| Jun 30, 2023 | -223,000.00 |
| Mar 31, 2023 | -104.42 Mn |
| Dec 31, 2022 | -87.90 Mn |
| Sep 30, 2022 | -72.88 Mn |
| Jun 30, 2022 | -59.29 Mn |
| Mar 31, 2022 | -47.30 Mn |
| Dec 31, 2021 | -36.39 Mn |
| Sep 30, 2021 | -28.17 Mn |
| Jun 30, 2021 | -21.99 Mn |